407. Regulatory Runaround: Does the Gluten Free Label Really Protect the Public?

FNCE Recorded Sessions from 2018

This presentation will explore this issue and detail efforts to encourage more enforcement by the FDA of its own labeling rule.

  • SKU FNCE18407
Member Price
$32.00
Nonmember Price
$37.00

This product is free for those who attended FNCE® 2018.

The Food and Drug Administration's (FDA) gluten-free labeling rule essentially established the definition of the term 'gluten-free.' Though the term is intended to help consumers easily identify gluten-free foods and provide assurance that gluten-free labeled foods are safe to consume, recently there have been multiple incidences of food labeled gluten-free that contain ingredients disallowed under the rule ("facial misbranding"). This presentation will explore this issue and detail efforts to encourage more enforcement by the FDA of its own labeling rule. The session will also analyze precautionary statements on labels, such as the Allergen Advisory Statement, which may confuse patients and professionals alike and have not reliably predicted gluten contamination.

CPEU: 1.5
CPE Level: 2
Learning Codes: 5220, 4010, 7010

Learning Objectives

  • Discuss the issues surrounding the misbranding of some labeled gluten-free foods.
  • Recognize the limitations of Allergen Advisory Statements in predicting gluten-contamination in foods.
  • Explain to consumers how to interpret Allergen Advisory statements on labeled gluten-free foods.

Speaker

  • Tricia Thompson, MS, RD
  • Amy Keller,
  • ,
  • ,

Moderator

  • Mary Sharrett, MS, RD, LD

Planned with the Medical Nutrition Practice Group

  • SKU FNCE18407